All Keywords
A randomized trial supports the recommendation to continue treatment with ACEi or ARBs during hospitalization for COVID-19
[Category] Fulltext, SARS,
[Article Type] Comment
[Source] pubmed
Communicable Diseases Research
감염병 연구데이터